AGP Executive Report
Last update: 7 hours agoObesity & Liver Health: Novo Nordisk reports that in a post hoc analysis of a semaglutide (Wegovy) trial, liver fat returned to normal in 23 of 26 adults with obesity by week 72—an 88.5% result, presented at EASD in Milan. Public Health Access: Eurostat data show Italy has 3.7 mammography units per 100,000 people (vs Cyprus at 6.9), while screening participation remains low across much of the EU. Alcohol Trends: A Europe-wide market analysis finds shoppers are cutting alcohol spending in several countries including Italy, while sales of low- and no-alcohol drinks rise. Healthcare Workforce: A report says the number of hospital doctors quitting increased sharply last year, raising pressure on staffing. Food & Safety: A pasta recall expanded to more lots sold at Walmart over listeria risk, while other food recalls continue to circulate. Wellness & Lifestyle: Coverage highlights “Blue Zone” longevity in Sardinia and how Mediterranean-style eating remains linked to healthier patterns. Italy in Global Health/Industry: Oman plans to showcase pharmaceutical investment opportunities at Milan’s Pharmaceuticals Exhibition, aiming to grow local clusters and exports.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
